Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
1998-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving the drugs in different
combinations may kill more tumor cells.
PURPOSE: Randomized phase II double-blinded trial to study the effectiveness of paclitaxel
and carboplatin given with either amifostine or placebo in patients with metastatic stage III
or stage IV ovarian cancer or metastatic stage III or stage IV non-small cell lung cancer.